Clinical Trials
3 trialsNCT05263583 2025-01-14
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Cothera Bioscience, Inc
Phase 2 Active not recruiting
NCT01007292 2015-10-19
A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Astellas Pharma Inc
Phase 2 Completed
NCT00818480 2015-09-04
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
Astellas Pharma Inc
Phase 2 Completed